Global Market Reach Iridex’s products are sold in over 100 countries through a network of more than 70 independent distributors, presenting a significant opportunity to expand distribution partnerships and tap into emerging markets.

Innovative Technology The company's development of versatile laser-based systems and MicroPulse technology for retinal diseases suggests opportunities to introduce these advanced solutions to clinics seeking minimally invasive and effective treatments.

Financial Growth With recent quarterly revenues between 50 million and 100 million dollars and ongoing funding, Iridex demonstrates healthy financials, enabling potential for strategic sales initiatives and new product launches.

Market Focus Iridex specializes in treatments for glaucoma, retinal diseases, and ENT disorders, providing targeted sales opportunities in ophthalmology and ENT markets where demand for innovative laser solutions is increasing.

Workforce & Support With a dedicated technical, clinical, and service support team, Iridex offers established partnerships for training, device support, and upgraded systems, enhancing opportunities for long-term customer retention and expansion.